Franck Morceau
- Molecular Medicine top 0.5%
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 4
- Hematology top 5%
- Erythropoietin and Anemia Treatment 5
- Molecular Biology top 5%
- Genomics, phytochemicals, and oxidative stress 13
- Glutathione Transferases and Polymorphisms 9
- Retinoids in leukemia and cellular processes 6
- Histone Deacetylase Inhibitors Research 6
- Epigenetics and DNA Methylation 6
- Genetics top 5%
-
- Erythrocyte Function and Pathophysiology 8
- Co-authors
- Marc DiederichMario DicatoMichaël SchnekenburgerSébastien ChateauvieuxAnnelyse DuvoixSylvie DelhalleRomain BlasiusEstelle Henry
- Journals
- Biochemical Pharmacology (16 papers)Cancer Letters (5 papers)Annals of the New York Academy of Sciences (4 papers)
- Partner nations
- LuxembourgFranceSouth Korea
In The Last Decade
Franck Morceau
44 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Medicine 567
- Toxicology 102
- Hematology 328
- Molecular Biology 1.5k
- Genetics 206
Countries citing papers authored by Franck Morceau
This map shows the geographic impact of Franck Morceau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Morceau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Morceau more than expected).
Fields of papers citing papers by Franck Morceau
This network shows the impact of papers produced by Franck Morceau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Morceau. The network helps show where Franck Morceau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franck Morceau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2018 | 55 | |
| 3 | 2015 | 12 | |
| 4 | 2015 | 34 | |
| 5 | 2013 | 7 | |
| 6 | 2011 | 45 | |
| 7 | 2010 | 68 | |
| 8 | 2009 | 50 | |
| 9 | 2009 | 72 | |
| 10 | 2008 | 12 | |
| 11 | 2008 | 51 | |
| 12 | 2004 | 54 | |
| 13 | Chemopreventive and therapeutic effects of curcuminbreakdown → | 2004 | 729 |
| 14 | 2004 | 16 | |
| 15 | 2003 | 11 | |
| 16 | 2003 | 40 | |
| 17 | 2003 | 62 | |
| 18 | 2001 | 22 | |
| 19 | 2001 | 24 | |
| 20 | 1996 | 35 |
About Franck Morceau
Franck Morceau is a scholar working on Toxicology, Hematology and Molecular Medicine, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (13 papers), Glutathione Transferases and Polymorphisms (9 papers), Erythrocyte Function and Pathophysiology (8 papers), Retinoids in leukemia and cellular processes (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Epigenetics and DNA Methylation (6 papers), Erythropoietin and Anemia Treatment (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). The work is most often cited by research in Molecular Medicine (567 citations), Toxicology (102 citations) and Hematology (328 citations). Franck Morceau has collaborated with scholars based in Luxembourg, France and South Korea. Frequent co-authors include Marc Diederich, Mario Dicato, Michaël Schnekenburger, Sébastien Chateauvieux, Annelyse Duvoix, Sylvie Delhalle, Romain Blasius, Estelle Henry, Anthoula Gaigneaux and Marie‐Madeleine Galteau. Their work appears in journals such as Biochemical Pharmacology, Cancer Letters, Annals of the New York Academy of Sciences, Leukemia Research and BioFactors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.